Porous silicon microparticle-based cancer vaccines and methods for potentiating anti-tumoral immunity

Keyphrases

• Microparticles 100%
• Tumor Immunity 100%
• Porous Silicon Nanoparticles 100%
• Cancer Vaccine 100%
• Cell-based 50%
• Nanomedicine 50%
• Cancer Immunotherapy 50%
• Ischemia 50%
• Asthma 50%
• Autoimmune Disease 50%
• Alzheimer's Disease 50%
• Glomerulonephritis 50%
• Diabetes 50%
• Ischemia-reperfusion Injury 50%
• Inflammatory Bowel Disease 50%
• Celiac Disease 50%
• Cancer Treatment 50%
• Acne 50%
• Infectious Diseases 50%
• Rheumatoid Arthritis 50%
• Illness 50%
• Irritable Bowel Syndrome 50%
• Colitis 50%
• Sarcoidosis 50%
• Vaccine Types 50%
• Crohn's Disease 50%
• Transplant Rejection 50%
• Lupus 50%
• Pelvic Inflammatory Disease 50%
• Autoinflammatory Diseases 50%
• Vaccine Composition 50%
• Cancer Immunotherapeutics 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Microparticle 100%
• Porous Silicon 100%
• Tumor Vaccine 100%
• Diseases 50%
• Malignant Neoplasm 50%
• Nanomedicine 25%
• Adjuvant 25%
• Atherosclerosis 25%
• Immunotherapy 25%
• Autoimmune Disease 25%
• Alzheimer's Disease 25%
• Ischemia 25%
• Reperfusion Injury 25%
• Irritable Colon 25%
• Inflammatory Bowel Disease 25%
• Coeliac Disease 25%
• Sarcoidosis 25%
• Rheumatoid Arthritis 25%
• Inflammatory Arthritis 25%
• Acne 25%
• Colitis 25%
• Asthma 25%
• Glomerulonephritis 25%
• Graft Rejection 25%
• Crohn's Disease 25%
• Dendritic Cell Vaccine 25%
• Autoinflammatory Disease 25%
• Pelvic Inflammatory Disease 25%